On March 18, Shimadzu Corporation opened the Shimadzu Kobe Innovation Lab (hereinafter, “Kobe Lab”) at the Kobe Biomedical Innovation Cluster located in Kobe city, Hyogo Prefecture. Kobe Lab will aim to expedite the development of useful microorganisms that can produce bioplastics from carbon dioxoide (CO2). By achieving a 200-fold increase in the current processing efficiency […]

THOUSAND OAKS, Calif. – Teledyne Technologies Incorporated (NYSE:TDY) (“Teledyne”​) announced today that Teledyne’s Board of Directors named George C. Bobb III as Teledyne’s President and Chief Executive Officer, effective immediately. Simultaneously, Edwin Roks has retired as Teledyne’s Chief Executive Officer, but will continue as a special advisor to Robert Mehrabian, Executive Chairman, through August 31, […]

Investment demonstrates confidence in America’s commitment to science and innovation WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four years, strengthening American innovation, manufacturing and economic competitiveness across the life sciences sector. As one of […]

Shimadzu Corporation has invested in RLWRLD Inc. (RLWRLD), through its Corporate Venture Capital (CVC) fund, “Shimadzu Future Innovation Fund” (Shimadzu FIF). RLWRLD is developing AI foundation models for humanoid and other types of robots used in the manufacturing industry. The reductions in the labor force caused by population decline and aging are emerging as social […]

Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays MUNICH–Bruker Corporation (NASDAQ: BRKR) today announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in […]

AMETEK, Inc. (NYSE: AME), is proud to announce the opening of its new Customer Solutions Center in Beijing. Designed to deliver exceptional localized customer experience, this state-of-the-art facility serves as a hub for comprehensive testing capabilities, interactive product demonstrations, and a collaborative framework for fostering innovation with Chinese customers in a wide range of applications. […]

The collaboration aims to provide advanced resources and scientific expertise to accelerate innovation and drive sustainable growth SINGAPORE — Thermo Fisher Scientific Inc, the world leader in serving science, has signed a strategic Memorandum of Understanding with NSG BIO, Singapore’s largest BSL-2-certified, co-working laboratory and office space. This collaboration aims to empower biotech startups in Singapore with access to […]

Shimadzu Scientific Instruments, Inc. (SSI, Columbia, Maryland, USA), a Shimadzu Group company, has opened a satellite lab in Boston, Massachusetts to be the base of its collaborative research and development activities on the East Coast. Established to conduct research and development more closely linked to customers, SSI’s R&D Center consists of three bases, with the […]

On February 21, Shimadzu Scientific Korea Corporation (SSK), a subsidiary of Shimadzu in South Korea, and Chungnam National University signed a memorandum of understanding (MOU) with the objectives of strengthening the development of technology and research equipment, and promoting collaborative research between industry and academia. Chungnam National University, which was established in 1952 in Daejeon […]

Shimadzu Corporation is establishing Shimadzu Oceania Pty. Ltd. (SOP) by integrating the sales subsidiaries in Australia on April 1, 2025. In Australia, Shimadzu Scientific Instruments Oceania Pty. Ltd. (SOPS), a sales subsidiary for analytical and measuring instruments, was established in 1991, and Shimadzu Medical Systems Oceania Pty. Ltd .(SOPM) a sales subsidiary for medical systems, […]